Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (251-260 of 289) with videos related to

Pageof 29
Sort By:
Blood|December 1, 1996
Lymphoma classification--the gap between biology and clinical management is closingW Hiddemann, D L Longo, B Coiffier, et al.
Blood|June 25, 1998
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)C Gisselbrecht, P Gaulard, E Lepage, et al.
Leukemia|August 12, 2005
Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 casesE Callet-Bauchu, L Baseggio, P Felman, et al.
British Journal of Haematology|October 29, 1998
Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignanciesN Ketterer, G Salles, I Moullet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patientsB D Cheson, J M Sorensen, D A Vena, et al.
Blood|May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantationN Ketterer, G Salles, M Raba, et al.
Blood|September 10, 1998
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II studyB Coiffier, C Haioun, N Ketterer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'AdulteB Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Bone Marrow Transplantation|November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myelomaC Thieblemont, C Dumontet, H Saad, et al.
Pageof 29

Showing results (251-260 of 289) with videos related to

Sort By:
Pageof 29
Blood|December 1, 1996
Lymphoma classification--the gap between biology and clinical management is closingW Hiddemann, D L Longo, B Coiffier, et al.
Blood|June 25, 1998
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA)C Gisselbrecht, P Gaulard, E Lepage, et al.
Leukemia|August 12, 2005
Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 casesE Callet-Bauchu, L Baseggio, P Felman, et al.
British Journal of Haematology|October 29, 1998
Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignanciesN Ketterer, G Salles, I Moullet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patientsB D Cheson, J M Sorensen, D A Vena, et al.
Blood|May 23, 1998
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantationN Ketterer, G Salles, M Raba, et al.
Blood|September 10, 1998
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II studyB Coiffier, C Haioun, N Ketterer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'AdulteB Coiffier, E M Neidhardt-Bérard, H Tilly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 TrialP Solal-Céligny, E Lepage, N Brousse, et al.
Bone Marrow Transplantation|November 20, 2002
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myelomaC Thieblemont, C Dumontet, H Saad, et al.
Pageof 29